Game ID | Player's Result | Player's Rating
Before & After | Player's Color | Name of Opponent | Oppon. ID | Oppon. Rating | Game Date |
Time Cntrl |
Opening Moves |
Event ID |
Comments |
68562 | WON | 600 626 | BLACK |
W.Abdullah | 7697-D | 600 | 11/17/07 | g/30 | | 277 | |
68568 | WON | 626 672 | WHITE |
T.Miron | 7662-R | 1148 | 11/17/07 | g/30 | | 277 | |
68580 | WON | 672 697 | BLACK |
M.Beller | 7698-H | 652 | 11/17/07 | g/30 | | 277 | |
68585 | WON | 697 743 | BLACK |
E.Barr | 7694-P | 1229 | 11/17/07 | g/30 | | 277 | |
68600 | DRAWN | 743 743 | WHITE |
J.Honnold | 7701-E | 682 | 11/17/07 | g/30 | | 277 | |
970042 | N/A | 743 1759 | N/A | *Rating Adjustment | n/a | (n/a) | 01/12/19 | | | | 1000-Point difference with USCF rating due to 11 year gap in CXR play. Russ Mollot and Ken Fee agree on need for R.A. |
970046 | WON | 1759 1761 | BLACK |
M.Czerniewski | 19663-N | 1054 | 01/25/19 | g/30 | | 1146 | January $$$ CASH Tournament |
970053 | LOST | 1761 1738 | WHITE |
T.Bergida | 19664-P | 1713 | 01/25/19 | g/30 | | 1146 | January $$$ CASH Tournament |
970060 | WON | 1738 1750 | WHITE |
N.Manley | 17502-T | 1507 | 01/25/19 | g/30 | | 1146 | January $$$ CASH Tournament |
970065 | LOST | 1750 1735 | BLACK |
K.Fee | 9103-E | 1903 | 01/25/19 | g/30 | | 1146 | January $$$ CASH Tournament |
970072 | LOST | 1735 1703 | WHITE |
N.Thomas | 18320-R | 1456 | 01/25/19 | g/30 | | 1146 | January $$$ CASH Tournament |
971696 | WON | 1703 1713 | WHITE |
E.Pattrick | 17347-T | 1419 | 02/22/19 | g/30 | | 1155 | February FREE ENTRY $$$CASH PRIZE Tournament |
983484 | WON | 1713 1715 | BLACK |
J.Merelestse | 19986-R | 1172 | 03/27/20 | g/30 | | 1302 | March Friday Night Free Cash Prize Tournament |
983490 | WON | 1715 1717 | WHITE |
E.Pattrick | 17347-T | 1247 | 03/27/20 | g/30 | | 1302 | March Friday Night Free Cash Prize Tournament |
983502 | WON | 1717 1719 | BLACK |
E.Lebedinsky | 20159-G | 1223 | 03/27/20 | g/30 | | 1302 | March Friday Night Free Cash Prize Tournament |
| Rating Adjustments are made by agreement between player's affiliate and CXR,
when the prevailing evidence supports its advisability. | |